~~<i id='E827C95802'><strike id='E827C95802'><tt id='E827C95802'><pre id='E827C95802'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

hotspot

author：comprehensive 2025-09-06 03:39:57 - browse：9954

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Live blog: Hearing on CRISPR

hotspot

knowledge

entertainment

hotspot

entertainment

MikeReddyforSTATWASHINGTON—Democratsunilaterallydrovemajorreformstothehealthinsuranceandthepharmaceu

WSS

A daunting task: navigating dual Medicare, Medicaid eligibility

Kidney transplant patients stopped immunosuppressants in trial

In key trial, Verve's treatment lowers cholesterol levels in patients

All of Us, NIH's precision medicine initiative, gets a big boost

What is microchimerism and how does it affect maternal health?

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

leisure time

hotspot

hotspot

Continuity nursing helped my family in our darkest PICU moments

After Sarepta trial failure, Duchenne families brace for more debate

After affirmative action ruling, medical educators look to 'holistic review'

Medicare must police algorithms in Medicare Advantage, Dems say

Dobbs anniversary: the lost opportunity of abortion as health care

Hospitals look to new technology to keep health care workers safe

Hepatitis C has a cure — but many Americans still lack access to it

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Peter Hotez and the public health issue of online harassment

Does good food count as health care? Study aims to find out

knowledge

Surge of respiratory disease in China has likely explanation

Live blog: Hearing on CRISPR

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Coloradans with cystic fibrosis could lose access to Trikafta

FDA's Woodcock to retire early next year

6:39Examined: How Putin keeps powerMar 12, 2021

entertainment

entertainment

hotspot

entertainment